Relative regional cerebral metabolic rate of glucose in rapid eye movement (REM) sleep and wakefulness was explored in combat veterans with and without posttraumatic stress disorder PTSD, using positron emission tomography. Hypermetabolism in brain regions involved in arousal regulation, fear responses, and reward processing persist during REM sleep in combat veterans with PTSD.
a b s t r a c t
Relative regional cerebral metabolic rate of glucose in rapid eye movement (REM) sleep and wakefulness was explored in combat veterans with and without posttraumatic stress disorder PTSD, using positron emission tomography. Hypermetabolism in brain regions involved in arousal regulation, fear responses, and reward processing persist during REM sleep in combat veterans with PTSD.
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Introduction
Posttraumatic stress disorder (PTSD) refers to symptoms of reexperiencing, avoidance, and hyperarousal that persist for more than one month after exposure to a traumatic event, such as combat. Nightmares, a cardinal symptom of PTSD, are prominently a phenomenon of rapid eye movement (REM) sleep. Objective REM sleep disruption has been associated with an increased risk of developing PTSD following trauma exposure (Mellman et al., 2002) . Thus, PTSD may be at least partially mediated by REM sleep mechanisms (Germain et al., 2008) .
Neuroimaging studies have shown that REM sleep offers a unique entry into the primitive emotional brain on a nightly basis through activation of the limbic system, the seat of emotional memories (Nofzinger et al., 1998) . Here, we used [ 18 F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) to explore metabolic changes in the limbic system during wakefulness and REM sleep in combat-exposed military veterans from Operations Enduring and Iraqi Freedom (OEF/OIF), with and without a diagnosis of PTSD.
Methods
This study was approved by the University of Pittsburgh Institutional Review Board. Eligible participants were OEF/OIF military veterans between 18 and 50 years-old, medication-free, and free of medical comorbidity. Eighteen veterans provided written, informed consent and completed a detailed diagnostic evaluation, as well as a physical examination with blood work and urine drug screen to determine health status and ascertain the absence of recent substance use. The Clinician Administered PTSD scale (Blake et al., 1995) was used to determine current PTSD status and severity. Eight veterans met diagnostic criteria for current PTSD, and 10 did not. The Structured Clinical Interview for DSM-IV (SCID; First et al., 1996) was used to verify the absence of comorbid Axis I disorders, including mood and alcohol/substance use disorders. All participants were free of psychiatric comorbidity. Current concussive symptoms were assessed with the Military Acute Concussion Evaluation (MACE; French et al., 2008) . None endorsed concurrent concussive symptoms at the time of the study. Two veterans with PTSD and one without PTSD endorsed a history of head injury with subsequent symptoms suggestive of a concussion, but denied receiving a formal diagnosis. Three other veterans without PTSD and two with PTSD reported being exposed to a blast of an explosion, but denied experiencing any concussive symptom at the time.
Participants slept for three nights in the sleep laboratory. The first night served as a screening night to rule out the presence of obstructive sleep apnea. The second night served as a baseline night, and data collected were used for group comparisons on objective polysomnography (PSG) sleep measures. Waking PET scans were acquired on the morning following the second night, 2 h after final awakening in the morning. Electroencephalography (EEG) was continuously monitored to ascertain that wakefulness 
